Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IKT | LYEL | PRLD | ||
| Company | Inhibikase Therapeutics Inc | Lyell Immunopharma Inc | Prelude Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.35 | 12.94 | 4.55 | ||
| High | 2.39 | 13.05 | 4.87 | ||
| Low | 2.27 | 12.56 | 4.19 | ||
| Latest | 2.31 | 12.99 | 4.64 | ||
| Change | -0.04 | +0.03 | +0.75 | ||
| % Change | -1.70% | +0.23% | +19.28% | ||
| Volume | 471,997 | 157,077 | 1,854,187 | ||
| 20-Day Average Volume | 1,095,965 | 170,229 | 400,459 | ||
| Previous Close | 2.35 | 12.96 | 3.89 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.11 | 13.80 | 4.50 | ||
| 20-Day Raw Stochastic | 64.52% | 13.21% | 45.31% | ||
| 20-Day Relative Strength | 66.44 | 43.92 | 54.67 | ||
| Weighted Alpha | +58.87 | -20.31 | +246.59 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 40% Buy | ||
| Last Month's Opinion | 64% Buy | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.59% since 07/21/26 | -0.92% since 07/21/26 | +14.85% since 07/21/26 | ||
| Low | 2.12 on 07/23/26 | 12.45 on 07/23/26 | 3.77 on 07/24/26 | ||
| High | 2.53 on 07/24/26 | 14.14 on 07/22/26 | 4.87 on 07/28/26 | ||
| 1-Month | |||||
| %Chg | +20.94% since 06/26/26 | +11.89% since 06/26/26 | +5.94% since 06/26/26 | ||
| Low | 1.84 on 06/29/26 | 11.84 on 06/29/26 | 3.77 on 07/24/26 | ||
| High | 2.53 on 07/24/26 | 16.80 on 07/08/26 | 5.69 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +22.87% since 04/28/26 | -39.55% since 04/28/26 | +5.69% since 04/28/26 | ||
| Low | 1.53 on 05/19/26 | 11.47 on 06/26/26 | 3.40 on 06/03/26 | ||
| High | 2.53 on 07/24/26 | 21.55 on 04/30/26 | 5.69 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | +45.28% since 01/28/26 | -45.94% since 01/28/26 | +135.53% since 01/28/26 | ||
| Low | 1.49 on 02/02/26 | 11.47 on 06/26/26 | 1.80 on 01/30/26 | ||
| High | 2.53 on 07/24/26 | 27.75 on 03/10/26 | 5.69 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 310,278 | 317,572 | 309,819 | ||
| Shares Outstanding, K | 132,033 | 24,504 | 79,645 | ||
| Annual Sales | 0 | 40,000 | 12,140,000 | ||
| Annual Net Income | -48,260,000 | -274,450,000 | -99,500,000 | ||
| Last Quarter Sales | 0 | 10,000 | 4,580,000 | ||
| Last Quarter Net Income | -16,380,000 | -140,720,000 | -10,390,000 | ||
| 60-Month Beta | 0.94 | -0.06 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 05/12/26 | -1.10 on 05/06/26 | -0.13 on 05/12/26 | ||
| Earnings Date | 08/13/26 | 08/11/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||